A bitter pill to swallow: young people dislike tablets more than old

Some patients surveyed preferred taking effervescent medicines. (Picture: Raymond Gilford/Flickr)

Changing pills to a more user-friendly formulation can increase patient compliance, brand loyalty, and extend IP exclusivity, says CMO Hermes in an exclusive podcast.

Kemwell CEO discusses green manufacturing

Kemwell CEO says environmental efforts are worth the cost

Capsule talks softegl tech at CPhI Frankfurt

Catalent launches softgel products at CPhI: one vegetarian, one anti-abuse

AlpVision's iPhone Tech Offers Authentication in War on Counterfeits

AlpVision's iPhone Tech Offers Authentication in War on Counterfeits

We asked experts how the regulators will cope with flexible risk-based monitoring systems

Is risk-based clinical trial monitoring too flexible for the regulators?

Cobra reflects on fill finish acqusition

Cobra Biologics talks recent fill finish acquisition and future growth plans

Catalent believes collaboration amongst industry and academia will drive drug delivery

Catalent says sharing with industry will not dull competetive edge

Bend Research hunting new partnerships

Bend Research hunting new partnerships to boost bioavailability offering

EU clinical trial laws: Clinipace comments

Changes to EU clinical trial laws will mean fairer playing field, says Clinipace

Value based drugs pricing: Market gap for outsource firms, Quintiles

Overhaul of EU health systems good opportunity for outcomes data providers, says Quintiles

See More audios